124 related articles for article (PubMed ID: 30077970)
1. Neurological manifestations of xeroderma pigmentosum due to
Salomão RPA; Pedroso JL; Barsottini OGP
Pract Neurol; 2018 Dec; 18(6):489-491. PubMed ID: 30077970
[No Abstract] [Full Text] [Related]
2. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
[TBL] [Abstract][Full Text] [Related]
3. Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series.
Zádori D; Szpisjak L; Németh IB; Reisz Z; Kovacs GG; Szépfalusi N; Németh VL; Maróti Z; Tóth-Molnár E; Oláh J; Vécsei L; Klivényi P; Kalmár T
Neurol Sci; 2020 Jan; 41(1):125-129. PubMed ID: 31478152
[TBL] [Abstract][Full Text] [Related]
4. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
5. Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.
Kindil Z; Senhaji MA; Bakhchane A; Charoute H; Chihab S; Nadifi S; Barakat A
BMC Res Notes; 2017 Dec; 10(1):704. PubMed ID: 29208038
[TBL] [Abstract][Full Text] [Related]
6. Truncated XPA protein detected in atypical group A xeroderma pigmentosum.
Mimaki T; Nitta M; Saijo M; Tachi N; Minami R; Tanaka K
Acta Paediatr; 1996 Apr; 85(4):511-3. PubMed ID: 8740317
[TBL] [Abstract][Full Text] [Related]
7. XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms.
Takahashi Y; Endo Y; Sugiyama Y; Inoue S; Iijima M; Tomita Y; Kuru S; Takigawa M; Moriwaki S
J Invest Dermatol; 2010 Oct; 130(10):2481-8. PubMed ID: 20574439
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
10. A novel 5 nucleotide deletion in XPA gene is associated with severe neurological abnormalities.
Ghafouri-Fard S; Fardaei M; Miryounesi M
Gene; 2016 Jan; 576(1 Pt 2):379-80. PubMed ID: 26302748
[No Abstract] [Full Text] [Related]
11. A novel XPA splice-site mutation identified in a 4-year-old Filipino girl with xeroderma pigmentosum.
Reyes HH; Lin YC; Hsu CK; Guevara BEK
Australas J Dermatol; 2023 May; 64(2):e165-e167. PubMed ID: 36866916
[TBL] [Abstract][Full Text] [Related]
12. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities.
Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S
Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
[TBL] [Abstract][Full Text] [Related]
14. CXCL1 Inhibition Regulates UVB-Induced Skin Inflammation and Tumorigenesis in Xpa-Deficient Mice.
Kunisada M; Hosaka C; Takemori C; Nakano E; Nishigori C
J Invest Dermatol; 2017 Sep; 137(9):1975-1983. PubMed ID: 28528167
[TBL] [Abstract][Full Text] [Related]
15. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.
Ramkumar HL; Brooks BP; Cao X; Tamura D; Digiovanna JJ; Kraemer KH; Chan CC
Surv Ophthalmol; 2011; 56(4):348-61. PubMed ID: 21684361
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
18. Relation of D.N.A. repair processes to pathological ageing of the nervous system in xeroderma pigmentosum.
Andrews AD; Barrett SF; Robbins JH
Lancet; 1976 Jun; 1(7973):1318-20. PubMed ID: 58310
[TBL] [Abstract][Full Text] [Related]
19. [Siblings with xeroderma pigmentosum group A showing mild cutaneous and various neurological manifestations].
Kuru S; Yasuma M; Sakai M; Konagaya M; Moriwaki S
Rinsho Shinkeigaku; 2006 Feb; 46(2):134-9. PubMed ID: 16619838
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
